Regulatory BCells in Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Systemic Lupus and Adverse Pregnancy Outcome
- Status
- UNKNOWN
- Phase
- N/A
Fatigue, Depression, and Cortical Excitability in Systemic Lupus
- Status
- UNKNOWN
- Phase
- N/A
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- N/A
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
- Status
- UNKNOWN
- Phase
- N/A
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
- Status
- RECRUITING
- Phase
- N/A
Compassionate Use for Subcutaneous (SC) Belimumab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Exercise and Arterial Stiffness in Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- NA
JBT-101 in Systemic Lupus Erythematosus (SLE)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Anti-Malarials in Incomplete Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of M2951 in SLE
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
- Status
- COMPLETED
- Phase
- PHASE2
ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
- Status
- COMPLETED
- Phase
- PHASE2
Dissemination of the Lupus Interactive Navigator
- Status
- COMPLETED
- Phase
- NA
Anti-infection of Low-does IL-2 in SLE
- Status
- COMPLETED
- Phase
- NA
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
- Status
- COMPLETED
- Phase
- PHASE2